VIRAL DYNAMICS AND EARLY VIRAL RESPONSE AT WEEK 4 IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON α2B AND RIBAVIRIN

被引:0
|
作者
Loaeza del Castillo, Aurora [1 ]
Sixtos-Alonso, S. [1 ]
Sanchez-Avila, F. [1 ]
Uribe, M. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1436
引用
收藏
页码:965A / 965A
页数:1
相关论文
共 50 条
  • [1] Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon α-2b and ribavirin
    Gallegos-Orozco, JF
    Loaeza-del Castillo, A
    Fuentes, AP
    García-Sandoval, M
    Soto, L
    Rodríguez, R
    Gutiérrez-Ruíz, MC
    Gutiérrez-Reyes, G
    Bonder, A
    Olivera, MA
    Kershenobich, D
    LIVER INTERNATIONAL, 2005, 25 (01) : 91 - 95
  • [2] Early viral kinetics in patients with chronic hepatitis C genotype 2 or 3 treated with peginterferon α-2a and ribavirin
    Scherzer, Th-M.
    Staufer, K.
    Steindl-Munda, P.
    Holzmann, H.
    Ferenci, P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S244 - S244
  • [3] Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin
    Gallegos-Orozco, JF
    Fuentes, AP
    Olivera-Martinez, MA
    Gutiérrez-Reyes, G
    Cortina, D
    Oregel, JA
    Pérez-Pruna, C
    Sixtos, MS
    Cruz-Castellanos, S
    Soto-Ramírez, LE
    Rodríguez-Díaz, R
    Fuentes-Romero, L
    Gutiérrez-Ruiz, MC
    Kershenobich, D
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2003, 55 (02): : 138 - 142
  • [4] Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4:: impact of treatment duration and viral kinetics on sustained virological response
    Kamal, SM
    El Tawil, AA
    Nakano, T
    He, Q
    Rasenack, J
    Hakam, SA
    Saleh, WA
    Ismail, A
    Aziz, AA
    Madwar, MA
    GUT, 2005, 54 (06) : 858 - 866
  • [5] Influence of insulin resistance and ribavirin dosage in viral dynamics of patients with chronic hepatitis C genotype 1 treated with peginterferon and ribavirin
    Grande, L.
    Madrazo, A.
    Viloria, M. M.
    Nogales, M. C.
    Corpas, R.
    Camacho, I.
    Sanchez-Munoz, D.
    Martin-Mazuelos, E.
    Romero-Gomez, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S241 - S241
  • [6] Early hepatitis C viral response (EVR) to peginterferon alfa 2a and ribavirin in patients with β thalassemia
    Harmatz, P
    Olivieri, NF
    Vichinsky, E
    Kwiatkowski, J
    Giardina, P
    Shah, F
    Elizabeth, WC
    Cunningham, M
    Maureen, J
    BLOOD, 2004, 104 (11) : 986A - 986A
  • [7] Impact of reducing peginterferon alfa-2b and ribavirin on early viral response in genotype 1 infected patients with chronic hepatitis C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Inoue, Yuko
    Kurashige, Nao
    Kurokava, Mika
    Yakushijin, Takayuki
    Igura, Takumi
    Imanaka, Kazuhiro
    Yoshihara, Harumosa
    Inoue, Atsuo
    Imai, Yasuharu
    Hayashi, Eijirou
    Kato, Michio
    Nishikawa, Masahiro
    Minami, Yuzo
    Tatsumi, Tomohide
    Kanto, Tatsuya
    Takehara, Tetsuo
    Kasahara, Akinori
    Tamura, Shinji
    Hayashi, Norio
    HEPATOLOGY, 2007, 46 (04) : 377A - 377A
  • [8] Analysis of early viral kinetics in chronic hepatitis C genotype 2 or 3 patients treated with peginterferon Alpha-2a and ribavirin
    Scherzer, Thomas-Matthias
    Staufer, Katharina
    Steindl-Munda, Petra
    Holzmann, Heidemarie
    Ferenci, Peter
    GASTROENTEROLOGY, 2007, 132 (04) : A789 - A789
  • [9] Oral administration of lactoferrin enhances viral decline in patients with genotype-1B-related chronic hepatitis C treated with peginterferon α-2B plus ribavirin
    Kumagai, N.
    Tsunematsu, S.
    Hamano, H.
    Yamauchi, K.
    Tsuchimoto, K.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2006, 84 (03): : 385 - 385
  • [10] IMPACT OF THE VIRAL KINETICS OF CHRONIC HEPATITIS C PATIENTS TREATED WITH TELAPREVIR IN COMBINATION WITH PEGYLATED INTERFERON α2b AND RIBAVIRIN
    Ogawa, E.
    Furusyo, N.
    Nakamuta, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S365 - S365